1. individuals who are taking cq for other indications 2. new use of nsaids 3. high risk background medications not limited to immunosuppressive regimens, steroids, anti-b cell therapies, anti-cytokine therapies, chemotherapies, janus kinase (jak)-inhibitors 4. individuals with a history of retinopathy that would contraindicate the use of cq 5. known allergy to cq or chloroquine 6. known qt prolongation and torsades de point 7. individuals who are pregnant or nursing

1. individuals who are taking cq for other indications 2. new use of nsaids 3. high risk background medications not limited to immunosuppressive regimens, steroids, anti-b cell therapies, anti-cytokine therapies, chemotherapies, janus kinase (jak)-inhibitors 4. individuals with a history of retinopathy that would contraindicate the use of cq 5. known allergy to cq or chloroquine 6. known qt prolongation and torsades de point 7. individuals who are pregnant or nursing

individuals who are taking cq for other indications new use of nsaids high risk background medications not limited to immunosuppressive regimens, steroids, anti-b cell therapies, anti-cytokine therapies, chemotherapies, janus kinase (jak)-inhibitors individuals with a history of retinopathy that would contraindicate the use of cq known allergy to cq or chloroquine known qt prolongation and torsades de point individuals who are pregnant or nursing

individuals who are taking cq for other indications new use of nsaids high risk background medications not limited to immunosuppressive regimens, steroids, anti-b cell therapies, anti-cytokine therapies, chemotherapies, janus kinase (jak)-inhibitors individuals with a history of retinopathy that would contraindicate the use of cq known allergy to cq or chloroquine known qt prolongation and torsades de point individuals who are pregnant or nursing

1. individuals who are taking cq for other indications 2. new use of nsaids 3. high risk background medications not limited to immunosuppressive regimens, steroids, anti-b cell therapies, anti-cytokine therapies, chemotherapies, janus kinase (jak)-inhibitors 4. individuals with a history of retinopathy that would contraindicate the use of cq 5. known allergy to cq or chloroquine 6. known qt prolongation and torsades de point 7. individuals who are pregnant or nursing

1. individuals who are taking cq for other indications 2. new use of nsaids 3. high risk background medications not limited to immunosuppressive regimens, steroids, anti-b cell therapies, anti-cytokine therapies, chemotherapies, janus kinase (jak)-inhibitors 4. individuals with a history of retinopathy that would contraindicate the use of cq 5. known allergy to cq or chloroquine 6. known qt prolongation and torsades de point 7. individuals who are pregnant or nursing